Schlünssen, V., Ádám, B., Momen, N. C., Nemery, B., Pega, F. & WHO/ILO Working Group on the Prevalences and Levels of Occupational Exposure to Dusts and/or Fibres (2023). Response to Letter to the Editor regarding "The prevalences and levels of occupational exposure to dusts and/or fibres (silica, asbestos and coal): A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury". Environment International, 179, Article 108165. https://doi.org/10.1016/j.envint.2023.108165

Ryo, L. B., Haslund, D., Rovsing, A. B., Pihl, R., Sanrattana, W., de Maat, S., Palarasah, Y., Maas, C., Thiel, S. & Mikkelsen, J. G. (2023). Restriction of C1-inhibitor activity in hereditary angioedema by dominant-negative effects of disease-associated SERPING1 gene variants. Journal of Allergy and Clinical Immunology, 152(5), 1218-1236.e9. https://doi.org/10.1016/j.jaci.2023.04.023

Fredsøe, J. H., Sandahl, M., Vedsted, P., Jensen, J. B., Ulhøi, B. P., Borre, M., Sørensen, K. D., Pedersen, B. G. & The PRIMA Study Group (2023). Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population. European Urology Oncology, 6(5), 484-492. https://doi.org/10.1016/j.euo.2023.07.006

Kjølhede, M., Andersen, G., Valentin, J. B., Nielsen, M. C., Andersen, M. N., Khan, M. B., Bech, J. N., Hess, D. C. & Blauenfeldt, R. A. (2023). Rheo-Erythrocrine Dysfunction as a Biomarker for Remote Ischemic Conditioning Treatment in Acute Ischemic Stroke: A Pilot Randomized Controlled Trial. Journal of the American Heart Association, 12(22), Article e031466. https://doi.org/10.1161/JAHA.123.031466

Vollmond, C. V., Tetens, M. M., Paulsen, F. W., Gerstoft, J., Kronborg, G., Johansen, I. S., Larsen, C. S., Wiese, L., Dalager-Pedersen, M., Leth, S., Mortensen, P. B., Lebech, A.-M., Obel, N. & Omland, L. H. (2023). Risk of Depression in People With Human Immunodeficiency Virus: A nationwide population-based matched cohort study. Clinical Infectious Diseases, 77(11), 1569-1577. https://doi.org/10.1093/cid/ciad415

Grosen, A. K., Mikkelsen, S., Baunwall, S. M. D., Dahlerup, J. F., Erikstrup, L. T., Hvas, C. L. & Erikstrup, C. (2023). Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules. Clinical Microbiology and Infection, 29(6), 799.e1-799.e4. https://doi.org/10.1016/j.cmi.2023.02.011

Rokkedrejer, S. I., Schlünssen, V., Kinnerup, M. B., Vestergaard, J. M., Kolstad, H. A. & Cramer, C. (2023). Risk of myocardial infarction among pigeon breeders: A follow-up study. Archives of Environmental and Occupational Health, 78(9-10), 507-511. https://doi.org/10.1080/19338244.2024.2302113

Reiter, N., Andersen, C. U., Thomsen, K. L., Wamberg, C. A., Petersen, T. S. & Dalhoff, K. (2023). Risk of prolonged sedation with the use of chlordiazepoxide in alcohol withdrawal treatment. Adverse Drug Reaction Bulletin, 340(1), 1319-1322. https://doi.org/10.1097/FAD.0000000000000068

Ammitzbøll, C., Kragh Thomsen, M., Bøgh Andersen, J., Jensen, J. M. B., From Hermansen, M.-L., Johannsen, A. D., Larsen, M., Mistegaard, C. E., Mikkelsen, S., Szabados, F., Vils, S. R., Erikstrup, C., Hauge, E.-M. & Troldborg, A. (2023). Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders. Rheumatology, 62(7), 2544–2549. https://doi.org/10.1093/rheumatology/keac666

Roos, I., Hughes, S., McDonnell, G., Malpas, C. B., Sharmin, S., Boz, C., Alroughani, R., Ozakbas, S., Buzzard, K., Skibina, O., van der Walt, A., Butzkueven, H., Scott, J. G., Kuhle, J., Terzi, M., Laureys, G., Van Hijfte, L., John, N., Grammond, P. ... MSBase Study GroupDanish MS Registry Study Group (2023). Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis. JAMA Neurology, 80(8), 789-797. https://doi.org/10.1001/jamaneurol.2023.1625

Govande, A. A., Babnis, A. W., Urban, C., Habjan, M., Hartmann, R., Kranzusch, P. J. & Pichlmair, A. (2023). RNase L-activating 2'-5' oligoadenylates bind ABCF1, ABCF3 and Decr-1. The Journal of general virology, 104(9), Article 104:001890. https://doi.org/10.1099/jgv.0.001890

Thomsen, K. L., Eriksen, P. L., Kerbert, A. JC., De Chiara, F., Jalan, R. & Vilstrup, H. (2023). Role of ammonia in NAFLD: An unusual suspect. JHEP Reports, 5(7), Article 100780. https://doi.org/10.1016/j.jhepr.2023.100780, https://doi.org/10.1016/j.jhepr.2023.100780

Gøkhan, M. A., Sørensen, E. S. & Baad-Hansen, L. (2023). Role of dairy proteins in the reduction of capsaicin-induced oral burning pain. Physiology & Behavior, 259, Article 114036. https://doi.org/10.1016/j.physbeh.2022.114036

Aggerholm-Pedersen, N., Baad-Hansen, T., Møller, H. J. & Sandfeld-Paulsen, B. (2023). Role of high‑sensitivity C‑reactive protein in patients with sarcoma. Oncology Letters, 26(6), Article 531. https://doi.org/10.3892/ol.2023.14118

Razdan, A., Schropp, L., Væth, M. & Kirkevang, L.-L. (2023). Root filled teeth in two parallel Danish cohorts: A repeated longitudinal cohort study. International Endodontic Journal, 56(5), 558-572. https://doi.org/10.1111/iej.13901

Hokland, P. (2023). Rounding off our Global View series. British Journal of Haematology, 203(5), 710-711. https://doi.org/10.1111/bjh.19172

Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., Greve, B., Woltering, F., Bozorg, A., Gayfieva, M., Kaminski, H. J. & MG0003 study team (2023). Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. The Lancet Neurology, 22(5), 383-394. https://doi.org/10.1016/S1474-4422(23)00077-7

Leite, F. R. M., López, R., Møller, H. J. & Nascimento, G. G. (2023). Salivary cytokine expression after non-surgical periodontal therapy in smokers: 12-month follow-up. Journal of Periodontology, 94(7), 823-834. https://doi.org/10.1002/JPER.22-0556

Staun Larsen, L., Nyvad, B. & Baelum, V. (2023). Salivary fluoride levels after daily brushing with 5000 ppm fluoride toothpaste: A randomised, controlled clinical trial. European Journal of Oral Sciences, 131(3), Article e12934. https://doi.org/10.1111/eos.12934